Skip to main content

Advertisement

SpringerLink
Log in

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lenart BA, Neviaser AS, Lyman S et al (2008) Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int . doi:10.1007/s00198-008-0805-x

    PubMed  Google Scholar 

  2. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS (2008) An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury 39:224–231

    Article  PubMed  Google Scholar 

  3. Visekruna M, Wilson D, McKiernan FE (2008) Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab 93:2948–2952

    Article  PubMed  CAS  Google Scholar 

  4. Lenart BA, Lorich DG, Lane JM (2008) Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med 358:1304–1306

    Article  PubMed  CAS  Google Scholar 

  5. Bataille R (1996) Management of myeloma with bisphosphonates. N Engl J Med 334:529–530

    Article  PubMed  CAS  Google Scholar 

  6. Raje N, Woo SB, Hande K et al (2008) Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res 14(8):2387–2395

    Article  PubMed  CAS  Google Scholar 

  7. Kyle RA, Yee GC, Somerfield MR et al (2007) American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J Clin Oncol 25:2464–2472

    Article  PubMed  CAS  Google Scholar 

  8. Grasko J, Herrman RP, Vasikaran SD (2009) Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates. J Oral Maxillofac Surg 67(3):645–649

    Article  PubMed  Google Scholar 

  9. Wernecke G, Namduri S, Dicarlo EF, Schneider R, Lane J (2008) Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSSJ 4(2):123–127

    Article  Google Scholar 

  10. Bush LA, Chew FS (2008) Subtrochanteric femoral insufficiency fracture following bisphosphonate therapy for osseous metastases. Radiology Case Reports [online] 3:232 http://radiology.casereports.net/index.php/rcr/article/view/232/548

    Google Scholar 

  11. Yang KH, Won JH, Yoon HK et al (2007) High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model. Yonsei Med J 48:653–658

    Article  PubMed  CAS  Google Scholar 

  12. Zoledronic acid treatment (every 4 or 12 weeks) to prevent skeletal complications in advanced multiple myeloma patients (Z-MARK). http://www.clinicaltrials.gov/ct2/show/NCT00622505?term=zoledronic+acid+and+myeloma&rank=5

  13. Study of zoledronic acid administered monthly versus every 3 months in multiple myeloma and breast cancer patients who were treated with zoledronic acid the prior year. http://www.clinicaltrials.gov/ct2/show/NCT00424983?term=zoledronic+acid+and+myeloma&rank=6

  14. Bone marker assessment of multiple myeloma patients treated with aminobisphosphonates. http://www.clinicaltrials.gov/ct2/show/NCT00577642?term=bone+marker+assessment++myeloma&rank=1

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Core Clinical Pathology & Biochemistry, PathWest Laboratory Medicine, Royal Perth Hospital, GPO Box X2213, Perth, WA, 6847, Australia

    S. D. Vasikaran

  2. School of Surgery and Pathology, University of Western Australia, Perth, Australia

    S. D. Vasikaran

Authors
  1. S. D. Vasikaran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. D. Vasikaran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasikaran, S.D. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case--control study. Osteoporos Int 20, 1457–1458 (2009). https://doi.org/10.1007/s00198-009-0955-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-009-0955-5

Keywords

Search

Navigation